The 3 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 2.00, with a high estimate of 2.40 and a low estimate of 1.84. The median estimate represents a +191.97% increase from the last price of 0.69.
The current consensus among 3 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.12
Reporting Date Feb 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.